244 related articles for article (PubMed ID: 17088018)
1. Absence of TREM2 polymorphisms in patients with Alzheimer's disease and Frontotemporal Lobar Degeneration.
Fenoglio C; Galimberti D; Piccio L; Scalabrini D; Panina P; Buonsanti C; Venturelli E; Lovati C; Forloni G; Mariani C; Bresolin N; Scarpini E
Neurosci Lett; 2007 Jan; 411(2):133-7. PubMed ID: 17088018
[TBL] [Abstract][Full Text] [Related]
2. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.
Cuyvers E; Bettens K; Philtjens S; Van Langenhove T; Gijselinck I; van der Zee J; Engelborghs S; Vandenbulcke M; Van Dongen J; Geerts N; Maes G; Mattheijssens M; Peeters K; Cras P; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Cruts M; Sleegers K;
Neurobiol Aging; 2014 Mar; 35(3):726.e11-9. PubMed ID: 24119542
[TBL] [Abstract][Full Text] [Related]
3. Mutations in TREM2 lead to pure early-onset dementia without bone cysts.
Chouery E; Delague V; Bergougnoux A; Koussa S; Serre JL; Mégarbané A
Hum Mutat; 2008 Sep; 29(9):E194-204. PubMed ID: 18546367
[TBL] [Abstract][Full Text] [Related]
4. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis.
Neumann H; Takahashi K
J Neuroimmunol; 2007 Mar; 184(1-2):92-9. PubMed ID: 17239445
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous TREM2 mutations in frontotemporal dementia.
Borroni B; Ferrari F; Galimberti D; Nacmias B; Barone C; Bagnoli S; Fenoglio C; Piaceri I; Archetti S; Bonvicini C; Gennarelli M; Turla M; Scarpini E; Sorbi S; Padovani A
Neurobiol Aging; 2014 Apr; 35(4):934.e7-10. PubMed ID: 24139279
[TBL] [Abstract][Full Text] [Related]
6. What is 'early onset dementia'?
Miyoshi K
Psychogeriatrics; 2009 Jun; 9(2):67-72. PubMed ID: 19604328
[TBL] [Abstract][Full Text] [Related]
7. TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer's Disease and Schizophrenia.
Mori Y; Yoshino Y; Ochi S; Yamazaki K; Kawabe K; Abe M; Kitano T; Ozaki Y; Yoshida T; Numata S; Mori T; Iga J; Kuroda N; Ohmori T; Ueno S
PLoS One; 2015; 10(9):e0136835. PubMed ID: 26332043
[TBL] [Abstract][Full Text] [Related]
8. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.
Kleinberger G; Yamanishi Y; Suárez-Calvet M; Czirr E; Lohmann E; Cuyvers E; Struyfs H; Pettkus N; Wenninger-Weinzierl A; Mazaheri F; Tahirovic S; Lleó A; Alcolea D; Fortea J; Willem M; Lammich S; Molinuevo JL; Sánchez-Valle R; Antonell A; Ramirez A; Heneka MT; Sleegers K; van der Zee J; Martin JJ; Engelborghs S; Demirtas-Tatlidede A; Zetterberg H; Van Broeckhoven C; Gurvit H; Wyss-Coray T; Hardy J; Colonna M; Haass C
Sci Transl Med; 2014 Jul; 6(243):243ra86. PubMed ID: 24990881
[TBL] [Abstract][Full Text] [Related]
9. Disease-Associated Mutations of TREM2 Alter the Processing of N-Linked Oligosaccharides in the Golgi Apparatus.
Park JS; Ji IJ; An HJ; Kang MJ; Kang SW; Kim DH; Yoon SY
Traffic; 2015 May; 16(5):510-8. PubMed ID: 25615530
[TBL] [Abstract][Full Text] [Related]
10. A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature.
Dardiotis E; Siokas V; Pantazi E; Dardioti M; Rikos D; Xiromerisiou G; Markou A; Papadimitriou D; Speletas M; Hadjigeorgiou GM
Neurobiol Aging; 2017 May; 53():194.e13-194.e22. PubMed ID: 28214109
[TBL] [Abstract][Full Text] [Related]
11. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.
Ruiz A; Dols-Icardo O; Bullido MJ; Pastor P; Rodríguez-Rodríguez E; López de Munain A; de Pancorbo MM; Pérez-Tur J; Alvarez V; Antonell A; López-Arrieta J; Hernández I; Tárraga L; Boada M; Lleó A; Blesa R; Frank-García A; Sastre I; Razquin C; Ortega-Cubero S; Lorenzo E; Sánchez-Juan P; Combarros O; Moreno F; Gorostidi A; Elcoroaristizabal X; Baquero M; Coto E; Sánchez-Valle R; Clarimón J;
Neurobiol Aging; 2014 Feb; 35(2):444.e1-4. PubMed ID: 24041969
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical characterization of microglia in Nasu-Hakola disease brains.
Satoh J; Tabunoki H; Ishida T; Yagishita S; Jinnai K; Futamura N; Kobayashi M; Toyoshima I; Yoshioka T; Enomoto K; Arai N; Arima K
Neuropathology; 2011 Aug; 31(4):363-75. PubMed ID: 21118401
[TBL] [Abstract][Full Text] [Related]
13. Candidate gene analysis of IP-10 gene in patients with Alzheimer's disease.
Venturelli E; Galimberti D; Fenoglio C; Lovati C; Finazzi D; Guidi I; Corrà B; Scalabrini D; Clerici F; Mariani C; Forloni G; Bresolin N; Scarpini E
Neurosci Lett; 2006 Aug; 404(1-2):217-21. PubMed ID: 16787707
[TBL] [Abstract][Full Text] [Related]
14. Clinical and psychometric distinction of frontotemporal and Alzheimer dementias.
Liscic RM; Storandt M; Cairns NJ; Morris JC
Arch Neurol; 2007 Apr; 64(4):535-40. PubMed ID: 17420315
[TBL] [Abstract][Full Text] [Related]
15. Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice.
Jadhav VS; Lin PBC; Pennington T; Di Prisco GV; Jannu AJ; Xu G; Moutinho M; Zhang J; Atwood BK; Puntambekar SS; Bissel SJ; Oblak AL; Landreth GE; Lamb BT
Mol Neurodegener; 2020 Oct; 15(1):62. PubMed ID: 33115519
[TBL] [Abstract][Full Text] [Related]
16. TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.
Pottier C; Wallon D; Rousseau S; Rovelet-Lecrux A; Richard AC; Rollin-Sillaire A; Frebourg T; Campion D; Hannequin D
J Alzheimers Dis; 2013; 35(1):45-9. PubMed ID: 23380991
[TBL] [Abstract][Full Text] [Related]
17. Homozygous TREM2 mutation in a family with atypical frontotemporal dementia.
Le Ber I; De Septenville A; Guerreiro R; Bras J; Camuzat A; Caroppo P; Lattante S; Couarch P; Kabashi E; Bouya-Ahmed K; Dubois B; Brice A
Neurobiol Aging; 2014 Oct; 35(10):2419.e23-2419.e25. PubMed ID: 24910390
[TBL] [Abstract][Full Text] [Related]
18. A novel homozygous mutation in TREM2 found in a Chinese early-onset dementia family with mild bone involvement.
Li X; Sun Y; Gong L; Zheng L; Chen K; Zhou Y; Gu Y; Xu Y; Guo Q; Hong Z; Ding D; Fu J; Zhao Q
Neurobiol Aging; 2020 Feb; 86():201.e1-201.e7. PubMed ID: 30797549
[TBL] [Abstract][Full Text] [Related]
19. BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease.
Venturelli E; Villa C; Fenoglio C; Clerici F; Marcone A; Benussi L; Ghidoni R; Gallone S; Cortini F; Serpente M; Cantoni C; Fumagalli G; Ridolfi E; Cappa S; Binetti G; Franceschi M; Rainero I; Giordana MT; Mariani C; Bresolin N; Scarpini E; Galimberti D
J Alzheimers Dis; 2011; 23(4):701-7. PubMed ID: 21157029
[TBL] [Abstract][Full Text] [Related]
20. Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease.
Giraldo M; Lopera F; Siniard AL; Corneveaux JJ; Schrauwen I; Carvajal J; Muñoz C; Ramirez-Restrepo M; Gaiteri C; Myers AJ; Caselli RJ; Kosik KS; Reiman EM; Huentelman MJ
Neurobiol Aging; 2013 Aug; 34(8):2077.e11-8. PubMed ID: 23582655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
